| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.0059 | 1 |